Nilotinib
ATC L01EA03 · 10 markets · 103 records
US 28 records · 7 strengths
AU 15 records · 5 strengths
- 150 mgcapsuleCeahaniMSN-NILOTINIB、NILOTAS、Tasigna
- 200 mgcapsuleCeahaniMSN-NILOTINIB、NILOTAS、Tasigna
- 227.38 mgcapsuleNILOTINIB-TEVA nilotinib (as hydrochloride) 150 mg capsule blister pack
- 170.54 mgcapsuleNILOTINIB-TEVA nilotinib (as hydrochloride) 150 mg capsule blister pack
Records without a stated strength · 1 Ceahani、MSN-NILOTINIB、NILOTAS、NILOTINIB VIATRIS、Tasigna
CN 15 records · 3 strengths
ES 11 records · 3 strengths
- 150 mgcapsuleNILOTINIB ACCORDNILOTINIB STADA、NILOTINIB TEVA、NILOTINIB ZENTIVA、Tasigna
- 200 mgcapsuleNILOTINIB ACCORDNILOTINIB STADA、NILOTINIB TEVA、NILOTINIB ZENTIVA、Tasigna
- 50 mgcapsuleNILOTINIB ACCORD
GB 9 records · 3 strengths
CA 9 records · 3 strengths
- 150 mgcapsuleAPO-NILOTINIBPMS-NILOTINIB、REDDY-NILOTINIB、Tasigna
- 200 mgcapsuleAPO-NILOTINIBPMS-NILOTINIB、REDDY-NILOTINIB、Tasigna
- 50 mgcapsuleREDDY-NILOTINIB
HK 4 records · 1 strengths
Records without a stated strength · 1 APO-NILOTINIB HARD CAPSULES 150MG、Tasigna
SG 2 records · 2 strengths
EU 2 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 NILOTINIB ACCORD、Tasigna
| Strength / form / release | US | GB | CA | AU | SG | CN | ES | HK | EU |
|---|---|---|---|---|---|---|---|---|---|
| 150 mgRecorded as: 0.15 g capsule | No trade name Tasigna | No trade name Tasigna | APO-NILOTINIB PMS-NILOTINIB REDDY-NILOTINIB+1Tasigna | Ceahani MSN-NILOTINIB NILOTAS+1Tasigna | Tasigna | Manufacturer: 苏州特瑞药业股份有限公司 ×4 Manufacturer: 齐鲁制药有限公司 ×2 达希纳尼洛替尼 | NILOTINIB ACCORD NILOTINIB STADA NILOTINIB TEVA | ||
| 200 mgRecorded as: 0.2 g capsule | No trade name Tasigna | No trade name Tasigna | APO-NILOTINIB PMS-NILOTINIB REDDY-NILOTINIB+1Tasigna | Ceahani MSN-NILOTINIB NILOTAS+1Tasigna | Manufacturer: 苏州特瑞药业股份有限公司 ×4 Manufacturer: 齐鲁制药有限公司 ×2 达希纳尼洛替尼 | NILOTINIB ACCORD NILOTINIB STADA NILOTINIB TEVA | |||
| 50 mg capsule | No trade name Tasigna | Tasigna | REDDY-NILOTINIB | Tasigna | 达希纳尼洛替尼 | NILOTINIB ACCORD | |||
| 95 mg tablet | DANZITEN | ||||||||
| 80 mg tablet | CAVHANZA | ||||||||
| 71 mg tablet | DANZITEN | ||||||||
| 60 mg tablet | CAVHANZA | ||||||||
| 227.38 mg capsule | NILOTINIB-TEVA nilotinib (as hydrochloride) 150 mg capsule blister pack | ||||||||
| 170.54 mg capsule | NILOTINIB-TEVA nilotinib (as hydrochloride) 150 mg capsule blister pack | ||||||||
unknown | Ceahani MSN-NILOTINIB NILOTAS+2NILOTINIB VIATRIS Tasigna | APO-NILOTINIB HARD CAPSULES 150MG Tasigna | NILOTINIB ACCORD Tasigna |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Also called: 尼罗替尼 nickname
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.